In what is thought to be the first clinical trial of its kind, the Nestlé Research Center will examine if a specific blend of nutrients and probiotics can improve the health of mothers and babies when taken by mothers before conception and throughout pregnancy. This study is the latest collaboration between the EpiGen Global Research Consortium and the Nestlé Research Center .
1,800 women in the United Kingdom, Singapore and New Zealand will take part in the trial. It will assess if the nutritional blend helps the mother maintain healthy blood sugar, vitamin and mineral levels, sustain a healthy pregnancy, and promote the healthy growth and development of her infant.
The study will also examine how this diet will influence babies’ genes.
If results show a significant impact in reducing pregnancy complications and metabolic disorders in infants, it may strengthen the argument for providing nutritional advice to women before conception.
It is part of Nestlé’s commitment to 'Build knowledge leadership in children’s nutrition' and 'Lead the industry in nutrition and health research through collaboration'.
View an infographic on epignetics (pdf, 2Mb) and read the press release on the Nestlé Research Center website